https://www.selleckchem.com/products/dbet6.html There was no significant difference in the dose of non-target and contralateral breast using BT and EBRT boost. D to skin, lung, and D to heart were 58.6 Gy vs. 66.7 Gy ( = 0.0025), 32.6 Gy vs. 50.6 Gy ( = 0.0002), and 52.2 Gy vs. 58.1 Gy ( = 0.0009), respectively, while D to ribs was 44.3 Gy vs. 37.7 Gy ( = 0.0062). UDC overestimated D (lung) by 54% ( = 0.0001) and D (ribs) by 28% ( = 0.0003). Based on our biological dose summation method, the total dose of PTV in the breast is higher using BT boost than with EBRT. BT boost yields lower skin, lung, and heart doses, but higher dose to ribs. UDC overestimates lung and ribs doses. Based on our biological dose summation method, the total dose of PTV in the breast is higher using BT boost than with EBRT. BT boost yields lower skin, lung, and heart doses, but higher dose to ribs. UDC overestimates lung and ribs doses. External beam radiotherapy (EBRT) combined with brachytherapy (BT) is the standard mode of radical radiotherapy for locally advanced cervical cancer. The cumulative equivalent doses in 2 Gy per fraction (EQD ) is an important basis for estimating the probability of local control of tumors and monitoring the occurrence of side effects in normal tissues. The purpose of this study was to explore the predictive value of Excel forms based on an automatic calculation in radical adaptive BT for cervical cancer. A retrospective analysis of 119 patients suffering from cervical cancer, treated with radical radiotherapy. All patients were treated with EBRT and adaptive BT. EBRT prescribed dose was 42.0-50.4 Gy in 21-28 fractions. BT nominal prescribed dose was 28 Gy in 4 fractions, separated by one week. Total EQD prediction at nth ( = 1-3) BT (TEPB ) or actual cumulative EQD (ACEQD ) can be calculated automatically by inputting the physical dose based on an in-house designed application. The relationship bm, which allows for balance between the total dose to target volu